Linda-gail G. Bekker
Expertise in
6
conditions

Linda-gail G. Bekker

University Of Cape Town, 
Cape Town, WC, ZA 
Expertise in
6
conditions
University Of Cape Town, 
Cape Town, WC, ZA 

Overview

Linda-gail Bekker practices practicing medicine in Cape Town, South Africa.

Ms. Bekker is highly rated in 6 conditions, according to our data. Her clinical expertise encompasses HIV/AIDS, Severe Acute Respiratory Syndrome (SARS), Chlamydia, and Gonorrhea.

She is actively involved in clinical research, co-authoring 617 peer reviewed articles and participating in 7 clinical trials.

Gender

Female

Locations

University Of Cape Town, Cape Town, WC 8001, South Africa

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Our Family Our Future: A Resilience-oriented Family Intervention to Prevent Adolescent HIV/STI Infection and Depression in South Africa
Our Family Our Future: A Resilience-oriented Family Intervention to Prevent Adolescent HIV/STI Infection and Depression in South Africa
Enrollment Status: Completed
Publish Date: May 15, 2025
Intervention Type: Behavioral
Study Phase: Phase 3
Leveraging Community-based Platforms to Improve Access and Adherence to PrEP for Young Women in South Africa
Leveraging Community-based Platforms to Improve Access and Adherence to PrEP for Young Women in South Africa
Enrollment Status: Completed
Publish Date: April 27, 2025
Intervention Type: Behavioral
Study Phase: Not Applicable
Multilevel Comprehensive HIV Prevention Package for South African Adolescent Girls and Young Women
Multilevel Comprehensive HIV Prevention Package for South African Adolescent Girls and Young Women
Enrollment Status: Completed
Publish Date: January 20, 2025
Intervention Type: Behavioral
Study Phase: Not Applicable
An International, Multi-site, Bayesian Platform Adaptive, Randomized, Placebo-controlled Trial Assessing the Effectiveness of Candidate Agents in Mitigating COVID-19 Disease in Adults
An International, Multi-site, Bayesian Platform Adaptive, Randomized, Placebo-controlled Trial Assessing the Effectiveness of Candidate Agents in Mitigating COVID-19 Disease in Adults
Enrollment Status: Completed
Publish Date: March 26, 2024
Intervention Type: Drug
Study Drug: MMR II Vaccine
Study Phase: Phase 3
Standing Tall (Yima Nkqo): A Pilot Randomized Controlled Trial of a Community-Based Intervention to Improve Health Outcomes for Young Adults Newly Diagnosed With HIV in South Africa
Standing Tall (Yima Nkqo): A Pilot Randomized Controlled Trial of a Community-Based Intervention to Improve Health Outcomes for Young Adults Newly Diagnosed With HIV in South Africa
Enrollment Status: Unknown
Publish Date: March 18, 2024
Intervention Type: Other
Study Phase: Phase 2
A Pilot Prospective Cohort Evaluation of Uptake and Adherence to PrEP in Young South African Women
A Pilot Prospective Cohort Evaluation of Uptake and Adherence to PrEP in Young South African Women
Enrollment Status: Unknown
Publish Date: February 15, 2019
Intervention Type: Behavioral, Drug
Study Phase: Phase 4
An Open-Label, Randomized Crossover Study to Evaluate the Acceptability and Preference for Contraceptive Options in Healthy HIV-Uninfected Female Adolescents, 16-17 Years of Age, as Proxy for HIV Prevention Methods
An Open-Label, Randomized Crossover Study to Evaluate the Acceptability and Preference for Contraceptive Options in Healthy HIV-Uninfected Female Adolescents, 16-17 Years of Age, as Proxy for HIV Prevention Methods
Enrollment Status: Unknown
Publish Date: February 11, 2019
Intervention Type: Drug, Device
Study Phase: Not Applicable
View 6 Less Clinical Trials

617 Total Publications

Characterization of vaginal lactobacilli from South African women toward the development of a biotherapeutic to optimize the vaginal microbiome.
Characterization of vaginal lactobacilli from South African women toward the development of a biotherapeutic to optimize the vaginal microbiome.
Journal: Applied and environmental microbiology
Published: August 21, 2026

Frequently Asked Questions about Linda-gail G. Bekker

Is Linda-gail G. Bekker a top-rated expert for HIV/AIDS?

MediFind is an objective health platform that identifies experts based on real-world data. Linda-gail G. Bekker is classified as an Elite expert for HIV/AIDS, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Linda-gail G. Bekker participate in research or clinical trials?

Yes. Linda-gail G. Bekker has published 617 articles and abstracts on conditions like HIV/AIDS. You can view a list of Linda-gail G. Bekker's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Bekker's expertise for a condition
ConditionClose
    View All 17 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile